Dobutamine free base

• CAT Number: I026416
• CAS Number: 34368-04-2
• Molecular Formula: C18H23NO3
• Molecular Weight: 301.39
• Purity: 98%
• Synonyms: Dobutamine Free Base; LY81929; LY-81929; LY 81929
• Target: Neuronal Signaling
• Solubility: To be determined
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol
• InChI: InChI=1S/C18H23NO3/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15/h4-9,12-13,19-22H,2-3,10-11H2,1H3
• InChIKey: JRWZLRBJNMZMFE-UHFFFAOYSA-N
• SMILES: CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O

Dobutamine free base（Cat No.:I026416）is a synthetic catecholamine and beta-adrenergic agonist used primarily in the treatment of heart failure and cardiogenic shock. It works by stimulating beta-1 adrenergic receptors in the heart, leading to increased heart rate and contractility, which improves cardiac output and oxygen delivery. Dobutamine is commonly administered intravenously in hospital settings to stabilize patients with acute heart conditions. The free base form of dobutamine is a more concentrated version, typically converted into the salt form for easier administration. It is generally well tolerated, though side effects may include arrhythmias and increased heart rate.